Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19
Excerpt
Coronavirus disease 2019 (COVID-19) primarily being considered as a respiratory illness has been showing a highly diverse and anomalous array of symptoms since its origin in December 2019 [...]
Share and Cite
Rahman, M.; Rakhi, N.N. Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19. Adv. Respir. Med. 2021, 89, 90-91. https://doi.org/10.5603/ARM.a2020.0191
Rahman M, Rakhi NN. Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19. Advances in Respiratory Medicine. 2021; 89(1):90-91. https://doi.org/10.5603/ARM.a2020.0191
Chicago/Turabian StyleRahman, Mujibur, and Nadira Naznin Rakhi. 2021. "Risk Assessment and Prognostic Aspect of Coagulopathy in COVID-19" Advances in Respiratory Medicine 89, no. 1: 90-91. https://doi.org/10.5603/ARM.a2020.0191